Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose. This price model comes down to ...
While insurance will cover the shots, premiums could rise, the senator warned. Vermont Sen. Bernie Sanders, the incoming chair of the committee focused on health, on Tuesday called out Moderna for ...
The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
The Food and Drug Administration approved updated COVID-19 vaccines but put restrictions on who is eligible for the shots, Health and Human Services Secretary Robert F. Kennedy Jr. announced Wednesday ...
US residents’ ability to get COVID-19 vaccines this fall is about to change as US Food and Drug Administration leaders shift away from a one-size-fits-all approach, raising concerns among vaccine ...
Stocktwits on MSN
Pfizer stock on track for worst day in over 8 months as BofA flags faster COVID-19 product erosion
Pfizer provides Covid vaccine called Comirnaty in addition to an antiviral medication used to treat COVID-19 called Paxlovid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback